Companies: 10,795·Total market cap: $144.5T
Olema Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

OLMANASDAQHealthcare● Active
$10.06
$-0.25(-2.45%)
Market Cap$878505924
P/E Ratio
52W High$36.259
52W Low$3.89

Olema Pharmaceuticals, Inc.(OLMA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · OLMA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.16B$0.12B$0.09B$0.08B$0.05B
G&A Expenses$0.02B$0.02B$0.02B$0.02B$0.02B
Total Operating Expenses$0.18B$0.14B$0.10B$0.11B$0.07B
Operating Income($0.18B)($0.14B)($0.10B)($0.11B)($0.07B)
Operating Margin %(computed)
Interest Income$0.02B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B
Income Before Tax($0.16B)($0.13B)($0.10B)($0.10B)($0.07B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.16B)($0.13B)($0.10B)($0.10B)($0.07B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.87$-2.20$-2.14$-2.62$-1.79
Wtd Avg Shares0.09B0.06B0.05B0.04B0.04B
EBITDA($0.18B)($0.14B)($0.10B)($0.11B)($0.07B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Olema Pharmaceuticals, Inc.

关于Olema Pharmaceuticals, Inc.(OLMA)损益表

Olema Pharmaceuticals, Inc.(OLMA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,OLMA实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.16B)(净利率—)。

常见问题

OLMA · 4 问

Olema Pharmaceuticals, Inc.(OLMA)2025财年营收为$0.00B,同比down—%。

OLMA revenueOLMA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08